Moreover, a trend of substantial survival benefit was observed in patients with MLL3- or MLL4-low melanoma as compared to patients bearing MLL3- or MLL4-high melanoma when a high degree of CD8+ T-cell infiltration occurs (Fig. 2p). This evidence concerns the gene KMT2C and melanoma.